Colorado’s Bold Approach to Psychedelics
Colorado has long been at the forefront of bold drug policy. After voters approved decriminalization of certain psychedelics in 2022, the state is now turning its attention to whether one of the most controversial compounds — ibogaine — could be used as a treatment for addiction.
What Is Ibogaine?
Ibogaine is a naturally-occurring psychedelic derived from the root bark of an African shrub. For decades, advocates have claimed that a single ibogaine session can interrupt opioid withdrawal and reduce cravings. Some people even describe it as a “reset button” for the brain. But the substance is also powerful and risky, with side effects that can include heart complications.
The Debate in Colorado
In Colorado, researchers, lawmakers, and treatment providers are debating whether ibogaine deserves a place in recovery care. Supporters argue that the state’s opioid crisis demands innovative tools. In 2023, more than 1,600 Coloradans died from overdoses, most linked to fentanyl (CDC overdose data). Traditional approaches like medication-assisted treatment (MAT) remain crucial, but many believe psychedelic therapies could provide another option for those who don’t respond to conventional methods.
Potential Pilot Programs
Pilot programs are already being discussed. Under the framework of Colorado’s Natural Medicine Health Act, regulators can create licensed treatment centers where psychedelics are administered in carefully controlled environments. Advocates want ibogaine to be included, with strict medical oversight. They say safety concerns can be addressed through proper screening, monitoring, and aftercare.
Skeptics, however, warn against rushing in. The FDA has not approved ibogaine (FDA drug approval process), and most existing studies are small or conducted outside the U.S. Critics argue that Colorado should focus resources on proven methods like MAT, counseling, and harm reduction. Some addiction experts also worry that the hype around psychedelics could overshadow the need for comprehensive, long-term support.
Public Interest and Hope
Despite the controversy, public interest is high. People in recovery and their families are asking whether ibogaine could offer hope where other treatments have failed. Stories circulate of individuals who say the experience freed them from years of opioid dependency. For policymakers, the challenge is balancing that hope with evidence and safety.
What makes Colorado unique is its willingness to experiment. By legalizing supervised use of psychedelics like psilocybin, the state has already signaled it is open to alternatives. Considering ibogaine is the next step in that conversation.
A Broader Shift in Recovery
The debate reflects a broader shift: recovery is no longer viewed as one-size-fits-all. Just as some people thrive in 12-step programs while others rely on medication or therapy, psychedelic-assisted treatment may one day be another option. Colorado’s exploration of ibogaine is not about replacing existing methods, but about expanding the toolbox.
Whether ibogaine becomes part of Colorado’s official recovery strategy remains to be seen. But the discussion itself highlights the urgency of the crisis and the willingness to think creatively. For people battling addiction, even the possibility of new hope matters.
If you or a loved one is struggling with addiction, reach out to Avenues Recovery Center. With 15 beautiful addiction treatment centers across 7 states, recovery has never been closer to home.
You can find your way home today!